Rockwell Medical (NASDAQ:RMTI – Get Free Report) and Verano (OTCMKTS:VRNOF – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, valuation, institutional ownership, dividends, earnings and risk.
Analyst Ratings
This is a breakdown of current ratings and target prices for Rockwell Medical and Verano, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Rockwell Medical | 1 | 0 | 1 | 0 | 2.00 |
| Verano | 1 | 0 | 0 | 1 | 2.50 |
Rockwell Medical currently has a consensus price target of $2.00, indicating a potential upside of 207.22%. Given Rockwell Medical’s higher possible upside, research analysts clearly believe Rockwell Medical is more favorable than Verano.
Risk and Volatility
Insider and Institutional Ownership
23.3% of Rockwell Medical shares are owned by institutional investors. Comparatively, 9.0% of Verano shares are owned by institutional investors. 4.6% of Rockwell Medical shares are owned by insiders. Comparatively, 9.1% of Verano shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Profitability
This table compares Rockwell Medical and Verano’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Rockwell Medical | -7.98% | -15.41% | -9.62% |
| Verano | -41.68% | -9.54% | -4.51% |
Valuation and Earnings
This table compares Rockwell Medical and Verano”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Rockwell Medical | $69.26 million | 0.37 | -$5.31 million | ($0.15) | -4.34 |
| Verano | $878.59 million | 0.52 | -$341.86 million | ($0.98) | -1.29 |
Rockwell Medical has higher earnings, but lower revenue than Verano. Rockwell Medical is trading at a lower price-to-earnings ratio than Verano, indicating that it is currently the more affordable of the two stocks.
Summary
Verano beats Rockwell Medical on 8 of the 15 factors compared between the two stocks.
About Rockwell Medical
Rockwell Medical, Inc., together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis. It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including testing supplies, 5% acetic acid cleaning solution, 5% and 2% citric acid descaler, filtration salts, and other items used by hemodialysis providers. The company's hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream. The company serves to hemodialysis clinics. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.
About Verano
Verano Holdings Corp. operates as a vertically integrated multi-state cannabis operator in the United States. The company engages in the cultivation, processing, wholesale, and retail distribution of cannabis in Arizona, Arkansas, Connecticut, Florida, Illinois, Maryland, Massachusetts, Michigan, Nevada, New Jersey, Ohio, Pennsylvania, and West Virginia. It offers cannabis products under the Encore, Avexia, MUV, Savvy, BITS, and Verano brands for medical and adult-use markets. The company is headquartered in Chicago, Illinois.
Receive News & Ratings for Rockwell Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rockwell Medical and related companies with MarketBeat.com's FREE daily email newsletter.
